What is the difference between lump-sum payments and running royalties?

A lump-sum payment is a one-off fee for the licensed patent rights, while running royalties are ongoing payments linked to sales, revenue, units, or other performance measures.

What are minimum annual royalties in a patent licence?

Minimum annual royalties require the licensee to pay a set minimum amount each year, helping the patent owner ensure the licence is actively exploited.

When are milestone payments used in patent licensing?

Milestone payments are triggered by agreed events, such as product development, regulatory approval, first commercial sale, or reaching sales targets.

What does net sales mean in a patent royalty clause?

Net sales usually means sales revenue after agreed deductions, such as VAT, refunds, discounts, rebates, shipping, or returns, depending on the licence wording.

How are patent royalty payments reported?

Patent licence agreements usually require the licensee to provide periodic royalty statements, sales records, and payment reports, often quarterly or annually.

Why include an audit clause in a UK patent licence agreement?

An audit clause allows the patent owner to inspect the licensee’s records to verify royalty calculations and underpayments, subject to agreed limits and confidentiality.

Are patent royalty payments taxable in the UK?

UK patent royalties may be subject to tax, withholding tax, VAT, or cross-border tax rules depending on the parties and transaction structure. Professional tax advice is recommended.

Can patent royalties be paid in a foreign currency?

Yes. Currency, exchange rates, payment timing, bank charges, and withholding taxes should be clearly addressed, especially for international patent licences.

What happens if a licensee pays royalties late?

Late payment clauses can require interest, suspend licence rights, trigger default procedures, or allow termination if payment is not made within an agreed cure period.

What payment terms should a Patent Licence Agreement include?

A well-drafted agreement should state the payment model, royalty rate, calculation method, reporting duties, audit rights, tax treatment, payment dates, and consequences of non-payment.

EN-GB>IP>Patent Licence Agreement>UK Patent Licence Royalty And Payment Models

Patent Licence Royalty And Payment Models In The United Kingdom

Created: 9 Jun 2026

This guide explains common royalty structures and payment models used in patent licensing, helping readers compare practical options and draft clearer terms. It is especially relevant for anyone preparing an AI Generated British Patent Licence Agreement.

How it works	Complexity level	Accounting requirements	Key considerations
Fixed fee
Licensee pays a set amount for defined patent rights, regardless of sales volume.	Simple	Invoice records, payment receipts, VAT records, and any staged due dates.	Useful where future sales are uncertain may underprice a highly successful product.
Upfront fee
Licensee pays an initial fee when the patent licence is signed or becomes effective.	Simple	Signed agreement, invoice, receipt, VAT treatment, and allocation against later royalties if applicable.	Improves licensor cash flow should state whether refundable, creditable, or separate from royalties.
Running royalty
Licensee pays a percentage of sales revenue for licensed products during each royalty period.	Moderate	Royalty statements, net sales calculations, deductions, returns, credits, and audit trail.	Define Net Sales precisely, including discounts, rebates, tax, carriage, related-party sales, and bundled products.
Royalty is calculated on gross invoiced sales before agreed deductions.	Moderate	Invoices, credit notes, sales ledger, VAT records, and reconciliation to royalty reports.	Simpler than net sales but may overstate value where returns, rebates, or distributor margins are material.
Royalty applies to revenue after permitted deductions from sales of licensed products.	Complex	Detailed deduction schedules, sales reports, returns, rebates, taxes, and product-level ledgers.	Deductions should be capped or tightly defined to avoid royalty erosion.
Per-unit royalty
Licensee pays a fixed amount for each licensed product made, sold, supplied, or imported.	Moderate	Unit counts, SKU records, manufacturing logs, shipment data, returns, and inventory reconciliations.	Avoids price manipulation but needs clear trigger events and treatment of samples, replacements, and scrap.
Royalty accrues when the licensee manufactures each patented product, whether or not sold.	Moderate	Production logs, batch records, stock write-offs, quality rejects, and reconciliation to finished goods.	Protects licensor from unsold stock strategies but may burden licensee before revenue is received.
Royalty accrues only when a licensed unit is sold or supplied to a customer.	Moderate	Sales invoices, dispatch records, return records, credit notes, and unit-level royalty reports.	Aligns payment with revenue needs rules for free samples, warranty replacements, and internal use.
Minimum annual royalty
Licensee must pay at least a stated annual amount, even if earned royalties are lower.	Moderate	Annual royalty reconciliation, shortfall invoices, payment calendar, and carry-forward records if allowed.	Supports active exploitation should state whether shortfalls are creditable against future royalties.
Exclusive licensee keeps exclusivity only if minimum annual royalty targets are met.	Moderate	Annual sales reports, royalty reconciliation, shortfall notices, and exclusivity status records.	Useful for exclusive licences include remedy such as conversion to non-exclusive rather than automatic termination.
Milestone payment
Payments become due when specified technical, regulatory, commercial, or funding events occur.	Moderate	Milestone evidence, acceptance records, regulatory correspondence, board approvals, and payment notices.	Milestones must be objective, dated where possible, and linked to events the licensee can evidence.
Payment is due when a licensed product obtains specified marketing authorisation or regulatory clearance.	Complex	Regulatory submissions, approval letters, territory records, and product authorisation evidence.	Define each regulator, territory, indication, and whether conditional or provisional approvals trigger payment.
Payments are triggered by trial commencement, patient dosing, endpoint achievement, or trial completion.	Complex	Clinical trial approvals, protocol records, dosing logs, trial reports, and milestone certificates.	Use precise trial definitions and decide whether partial, failed, repeated, or abandoned trials trigger payment.
Payment is due when cumulative sales or annual sales exceed a specified threshold.	Moderate	Cumulative sales ledger, threshold calculations, sales statements, and supporting invoices.	Should align with Net Sales definition and prevent manipulation through affiliates or delayed invoicing.
Revenue share
Parties split revenue generated from licensed patent exploitation under agreed percentages.	Complex	Revenue ledger, cost allocations if any, partner reports, deductions, and reconciliation statements.	Clearly define shared revenue, allowable costs, timing, sublicensing income, and audit rights.
Parties share net profit after agreed costs from exploitation of the licensed patent rights.	Complex	Revenue, direct costs, allocated overheads, tax assumptions, and periodic profit calculations.	Can be disputed unless costs, overheads, and transfer prices are tightly controlled.
Licensee pays the licensor a percentage of fees or royalties received from authorised sublicensees.	Complex	Sublicence agreements, sublicensing income statements, deductions, royalty reports, and audit records.	Define gross sublicensing income, non-cash consideration, pass-through costs, and approval rights.
Audit-adjusted royalty
Reported royalties may be corrected after inspection of licensee books and records.	Complex	Royalty records, invoices, ledgers, stock data, audit access logs, and adjustment calculations.	Audit clause should cover notice, frequency, confidentiality, underpayment interest, and audit cost shifting.
If an audit finds underpayment above a threshold, licensee pays the shortfall and audit costs.	Complex	Independent audit report, variance analysis, shortfall invoice, interest calculation, and remedial records.	Thresholds commonly incentivise accurate reporting ensure audit rights survive termination for past periods.
Royalty-free licence
Licensee receives patent rights without ongoing royalty payments, often for strategic or reciprocal value.	Simple	Licence records, consideration analysis, tax support, and compliance records for any non-payment obligations.	Consider tax, competition, exclusivity, sublicensing, termination, and whether non-monetary consideration is sufficient.
Each party grants patent rights to the other without monetary royalties.	Moderate	Patent schedules, field-of-use records, product mappings, and records of reciprocal rights.	Balance patent value, scope, improvements, defensive termination, and freedom-to-operate objectives.
Upfront fee, Running royalty
Licensee pays an initial fee plus ongoing royalties based on sales or units.	Moderate	Upfront invoice, royalty statements, sales records, deductions, and periodic reconciliation.	Balances immediate value and upside state whether upfront payment is creditable against royalties.
Fixed fee, Milestone payment
A base fee is payable, with extra sums due when agreed development or commercial events occur.	Moderate	Payment schedule, milestone evidence, invoices, acceptance certificates, and notice records.	Useful where value depends on later success milestone wording must avoid subjective disputes.
Running royalty, Minimum annual royalty
Sales royalties accrue normally, but the licensee pays a top-up if annual royalties fall short.	Moderate	Periodic royalty reports, annual reconciliation, shortfall calculations, and credit carry-forward records.	Encourages exploitation while preserving upside set realistic minimums by territory and field.
Running royalty
Royalty percentage changes when sales volumes or revenue bands are reached.	Complex	Band calculations, cumulative sales records, period resets, product-level revenue, and reconciliations.	Can reward scale or protect margins specify whether tiers are marginal or retrospective.
Royalty rate decreases as sales volumes increase or manufacturing economies improve.	Complex	Cumulative unit or revenue records, tier calculations, margin data, and royalty reconciliations.	May incentivise scaling ensure lower rates do not conflict with minimum revenue expectations.
Royalty rate increases over time or after sales thresholds are met.	Complex	Time-based rate tables, sales thresholds, royalty calculations, and change-date records.	Useful to support launch margins should not create unintended price or competition-law pressure.
Different royalty rates apply by territory covered by the licensed patent rights.	Complex	Territory-coded sales data, patent coverage schedules, currency conversion, and local tax records.	Match rates to patent coverage, market value, exchange rates, withholding tax, and local enforcement risk.
Different royalties apply depending on the licensed field, application, or market segment.	Complex	Field-coded sales records, product classification, customer use data, and audit evidence.	Field definitions must be commercially clear and enforceable without excessive monitoring burden.
Running royalty, Minimum annual royalty
Exclusive licensee pays higher royalties or minimums in return for sole exploitation rights.	Moderate	Exclusivity territory records, sales reports, minimum royalty reconciliation, and compliance certificates.	Exclusivity should be tied to performance obligations, diligence duties, and loss-of-exclusivity remedies.
Running royalty
Multiple licensees may use the patent and each pays a lower ongoing royalty.	Moderate	Separate licensee reports, royalty ledgers, product scopes, and confidentiality controls.	Licensor retains market flexibility manage confidentiality and most-favoured-licensee expectations carefully.
Audit-adjusted royalty, Running royalty
Royalty may adjust if the licensor grants more favourable comparable terms to another licensee.	Complex	Comparable licence records, confidential term summaries, adjustment notices, and reconciliation calculations.	Define comparable transactions, exclusions, confidentiality, and whether changes are automatic or prospective.
Running royalty
Running royalties stop or reduce once aggregate payments reach a specified cap.	Moderate	Cumulative royalty ledger, cap calculations, payment history, and confirmation of cap exhaustion.	May help investment modelling licensor should assess upside given patent life and market size.
Running royalty, Minimum annual royalty
Annual royalties are subject to a minimum floor and maximum cap.	Complex	Annual royalty calculations, floor top-ups, cap tracking, and payment reconciliations.	Gives budget certainty but can weaken incentives if caps are reached early.
Upfront fee, Running royalty
Licensee pays royalties in advance, later credited against earned running royalties.	Moderate	Advance payment ledger, earned royalty statements, credit balance, and expiry of unused credits.	Clarify whether advances are refundable, time-limited, transferable, or lost on termination.
Minimum annual royalty, Upfront fee
Licensee guarantees a minimum payment, often paid upfront or annually, regardless of sales.	Moderate	Guarantee schedule, invoices, payment records, royalty credit tracking if applicable.	Protects licensor downside licensee should model launch delays and market-entry risks.
Fixed fee
One payment buys a fully paid-up licence for the agreed term, territory, and field.	Simple	Payment receipt, licence scope records, tax records, and patent schedule maintenance.	Reduces administration licensor loses future upside unless new patents or improvements are excluded.
Running royalty
Royalty rate reduces as licensed patents expire, lapse, are revoked, or cease to cover products.	Complex	Patent status reports, product claim charts, expiry dates, territory coverage, and rate adjustments.	Important for portfolios specify effect of supplementary protection certificates and pending applications.
Royalties are owed only for products covered by at least one valid licensed patent claim.	Complex	Claim coverage analysis, patent status checks, product technical records, and legal opinions if disputed.	Reduces overpayment risk but may create technical disputes and require patent counsel input.
Royalty covers both patent rights and associated know-how, sometimes continuing after patent expiry for know-how value.	Complex	Allocation between patent and know-how value, sales records, expiry tracking, and rate-step records.	Separate patent and know-how consideration to reduce enforceability and competition-law risk.
Royalties on overseas sales are converted into pounds sterling using an agreed exchange-rate method.	Moderate	Foreign sales ledgers, exchange-rate source, conversion date, bank charges, and payment records.	Specify currency, exchange-rate source, conversion date, bank fees, and who bears exchange risk.
Fixed fee
Fixed periodic payments increase by CPI, RPI, or another agreed index.	Moderate	Index data, adjustment calculations, updated invoices, and payment schedule records.	Preserves real value define index, base month, rounding, caps, floors, and replacement index.
Fixed licence fee is paid later, often after launch, funding, or first commercial sale.	Simple	Due-date trigger evidence, invoice records, payment timetable, and late payment tracking.	Helps early-stage licensees licensor may need security, interest, or termination rights for non-payment.
Milestone payment
Payment is due only if the licensed technology reaches a defined success outcome.	Moderate	Objective success evidence, test results, approval records, and milestone notice records.	Reduces licensee risk licensor should include diligence obligations and anti-avoidance wording.
Fixed fee
Licensee pays fixed monthly, quarterly, or annual fees for continued access to patent rights.	Simple	Payment calendar, invoices, receipts, renewal records, and termination notices.	Predictable income define suspension or termination if periodic fees are missed.
Royalty-free licence
Licensee pays no royalties but grants back rights to improvements or related patents.	Complex	Improvement invention records, patent filings, grant-back notices, and scope tracking.	Grant-back clauses need careful competition-law review, especially if exclusive or innovation-restricting.
Patent rights are licensed without royalties for specified public-interest, research, or humanitarian uses.	Moderate	Use restrictions, eligibility records, territory records, compliance reports, and sublicence controls.	Define permitted purpose tightly and reserve commercial uses for paid licences if needed.
Audit-adjusted royalty
Licensee pays estimated royalties during the year, then true-up is made after final accounts or audit.	Complex	Estimated royalty schedules, management accounts, final accounts, true-up calculations, and audit reports.	Useful where final sales data lags define timing, interest, overpayment credits, and audit standards.
Running royalty, Minimum annual royalty, Milestone payment, Fixed fee
Interest accrues if licence payments are not made by the contractual due date.	Moderate	Due dates, payment receipts, overdue balances, interest calculations, and demand letters.	For UK business debts, contractual wording should align with or expressly replace statutory late payment rights.
Running royalty, Fixed fee, Milestone payment
Licensee grosses up payments so the licensor receives the agreed net amount after withholding tax.	Complex	Tax residence documents, withholding certificates, treaty relief forms, gross-up calculations, and remittance evidence.	Cross-border royalty payments may need tax advice on withholding, treaty relief, and payment responsibility.
Running royalty, Fixed fee
Group companies set patent royalty charges by reference to armu2019s length transfer pricing principles.	Complex	Benchmarking studies, intercompany agreements, transfer pricing files, invoices, and tax adjustments.	Rates must be supportable for UK tax purposes, especially where IP ownership and exploitation are split.
Fixed fee, Running royalty, Minimum annual royalty, Milestone payment, Upfront fee, Revenue share, Per-unit royalty
Payment obligations sit within a patent licence that may be registrable at the UK IPO.	Moderate	Executed licence, patent numbers, registration evidence, payment schedules, and royalty records.	UK patent licences should consider registration because registered interests affect priority and third-party notice.
Fixed fee, Running royalty, Minimum annual royalty, Milestone payment, Upfront fee, Revenue share, Per-unit royalty, Royalty-free licence
Payment and royalty terms are recorded in a written patent licence defining scope, parties, and consideration.	Simple	Signed licence, authorised signatories, payment terms, patent schedule, and amendments.	UK patent assignments and certain patent transactions require signed written instruments licences should be documented clearly.
Running royalty, Revenue share, Royalty-free licence, Minimum annual royalty
Royalty terms are combined with field, territory, exclusivity, grant-back, or output restrictions.	Complex	Licence restrictions, market data, exclusivity records, sublicence controls, and compliance reviews.	Avoid royalty or exclusivity terms that restrict competition beyond what is legally justifiable.

How Should A UK Patent Licence Set Royalties?

UK patent licence royalties should be drafted around measurable triggers: sales, units, milestones, sublicensing income, or a fixed timetable. The licence should define Net Sales, reporting periods, VAT treatment, exchange rates, deductions, late payment interest, audit rights, and whether payments survive expiry, invalidity, termination, or patent challenge.

Which Patent Licence Payment Model Is Easiest To Administer?

Fixed fees, upfront fees, and royalty-free licences are usually simplest because they require limited sales tracking. Running royalties, revenue share, and audit-adjusted royalties need stronger accounting controls, especially where the licensee sells bundled products, grants sublicences, or operates across multiple territories.

What UK Legal Issues Affect Patent Royalty Clauses?

Patent licences should normally be put in writing and signed if they grant or assign rights connected with UK patents; registration at the UK IPO can also affect enforceability against third parties. See the Patents Act 1977 section 30 and section 33.
Royalty structures must be competition-law aware. Restrictions or royalties that distort competition may be assessed under the Competition Act 1998 Chapter I prohibition.
Withholding tax, VAT, transfer pricing, and overseas payments can materially affect net receipts, so tax wording should be checked before finalising royalty rates.

Patent licence royalty and payment models

Want to Generate Your own Patent Licence Agreement?

Docaro AI can help you write your own Patent Licence Agreement for use in the United Kingdom in minutes.

Generate Your Document Now

FAQs

What royalty models are used in UK patent licence agreements?

Common models include fixed fees, running royalties based on sales or revenue, milestone payments, minimum annual royalties, lump-sum payments, and hybrid structures combining several methods.

What is a patent licence royalty?

How are patent royalties calculated in the United Kingdom?

Is there a standard patent royalty rate in the UK?

How does exclusivity affect patent licence royalties?

Show All FAQs